An urgently needed test for the most common form of liver cancer may soon be available. Liver cancer can be diagnosed without a biopsy, but the current test, which is ultrasound (US), has only 22% sensitivity.

The rate of this type of cancer is becoming more prevalent worldwide. Regular screening is recommended for people with risk factors like cirrhosis, chronic hepatitis B infection, or a family history of liver cancer. Early diagnosis is a key factor in survival.

Exact Sciences’ multiomic Oncoguard Liver blood test has several times the sensitivity of US and appears to have improved detection of early stage tumors. The blood-based assay was developed in collaboration with Mayo Clinic. It combines DNA methylation and protein markers to detect molecular signatures associated with

See Full Page